3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematologic Neoplasms
4
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Neoplasms
1
Mental Disorders
1
Lung Neoplasms
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Malignant Solid Neoplasm
1
Interventions
Cyclophosphamide
30
Rituximab
27
Biopsy
23
Specimen Handling
20
Magnetic Resonance Spectroscopy
18
fludarabine
14
Prednisone
13
Vincristine
11
obinutuzumab
10
Lenalidomide
10
Etoposide
10
Doxorubicin
10
Bendamustine Hydrochloride
9
venetoclax
7
pembrolizumab
7
fludarabine phosphate
6
X-Rays
6
Tacrolimus
6
Nuclear Medicine Department, Hospital
6
Dexamethasone
6
Bortezomib
6
trametinib
5
ibrutinib
5
glofitamab
5
acalabrutinib
5
Mycophenolic Acid
5
Gemcitabine
5
Crizotinib
5
Busulfan
5
copanlisib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Behavior Therapy
×
90 days
×
Clear all
No trials found.